Back to Search
RAMEZ DAGHER, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1235814237Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
33881(MN)
Research & Publications (20)
Calcium fingerprints induced by calmodulin interactors in eukaryotic cells.
PMID 19133300·Biochim Biophys Acta·2009
8-other
The psychosocial work environment and maternal postpartum depression.
PMID 19288209·Int J Behav Med·2009
8-other
Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma after one prior therapy.
PMID 18922829·Oncologist·2008
4-observational
Tasigna for chronic and accelerated phase Philadelphia chromosome--positive chronic myelogenous leukemia resistant to or intolerant of imatinib.
PMID 18765523·Clin Cancer Res·2008
8-other
Ixabepilone in combination with capecitabine and as monotherapy for treatment of advanced breast cancer refractory to previous chemotherapies.
PMID 18628451·Clin Cancer Res·2008
4-observational
Small neutralizing molecules to inhibit actions of the chemokine CXCL12.
PMID 18556651·J Biol Chem·2008
8-other
Solid-phase organic tagging resins for labeling biomolecules by 1,3-dipolar cycloaddition: application to the synthesis of a fluorescent non-peptidic vasopressin receptor ligand.
PMID 18512866·Chemistry·2008
8-other
Good clinical practice and the conduct of clinical studies in pediatric oncology.
PMID 18242321·Pediatr Clin North Am·2008
6-review
Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.
PMID 18448560·Oncologist·2008
8-other
Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma.
PMID 18077994·Oncology (Williston Park)·2007
3-trial
Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma.
PMID 17438089·Clin Cancer Res·2007
7-preclinical
Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.
PMID 17332278·Clin Cancer Res·2007
6-review
Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma.
PMID 17227905·Oncologist·2007
8-other
Population pharmacokinetic-based dosing of intravenous busulfan in pediatric patients.
PMID 17192508·J Clin Pharmacol·2007
3-trial
Review article: tolevamer, a novel toxin-binding polymer: overview of preclinical pharmacology and physicochemical properties.
PMID 17206941·Aliment Pharmacol Ther·2006
6-review
Topotecan in combination with cisplatin for the treatment of stage IVB, recurrent, or persistent cervical cancer.
PMID 17112001·Oncology (Williston Park)·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2312 S 6TH ST FL 2
MINNEAPOLIS, MN 55454 - Phone
- (612) 625-3330
Quick Facts
- NPI
- 1235814237
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile